The quest for optimal performance is paramount in the competitive arena of equine sports. A significant challenge in this pursuit is Exercise-Induced Pulmonary Hemorrhage (EIPH), a condition that, although not a disease, significantly impacts the health and performance of horses in high-stakes disciplines such as Barrel racing, Horse racing, Show Jumping, and Eventing.

Understanding EIPH Across Disciplines

EIPH, characterized by bleeding in the lungs due to ruptured pulmonary capillaries during intense exercise, is a significant concern across a wide range of equine sports. The 2024 Equine Health and Nutrition Conference Proceedings offer detailed insights into the prevalence of EIPH across disciplines, underscoring the condition's widespread impact. Notably (Bayly & Van Erck, 2024):

  • Thoroughbred Racehorses: The prevalence of EIPH is estimated to be between 44% and 75%, with the condition becoming almost ubiquitous (approaching 100%) when horses are subjected to multiple endoscopic examinations or diagnosed through bronchoalveolar lavage (BAL).
  • Standardbreds: Show a lower prevalence rate of 26%, highlighting variations in susceptibility among different racing breeds.
  • Racing Quarter Horses: Experience a prevalence rate of 62%, indicating a significant impact within this racing community.
  • Three-Day Event Horses: 40% of these athletes are affected, which may influence their performance across the competition's varied phases.
  • Show Jumpers: Face a 45% prevalence rate, affecting nearly half of the competitors in this high-intensity discipline.
  • Elite Endurance Horses: 40% prevalence rate, demonstrating the condition's effect even in long-distance competitions.
  • Polo Ponies: With an 11% prevalence, EIPH is less common but still a concern for the sport.
  • Draft Pulling Horses: A 26% prevalence rate shows that EIPH can affect horses outside traditional racing or performance disciplines.

Innovations in EIPH Management

Advances in Exercise-Induced Pulmonary Hemorrhage (EIPH) management without the use of drugs have reshaped the landscape for the care of equine athletes. These innovations include targeted treatments and diagnostic improvements that enhance our understanding and ability to manage this condition. A key focus has been reducing the factors exacerbating EIPH, leading to more effective prevention and management strategies (Bayly & Van Erck, 2024).

Harnessing the Power of FLAIR Strips

At the forefront of these advancements are FLAIR® Nasal Strips. By reducing airway resistance and optimizing respiratory function, FLAIR Strips directly address the stress failure of pulmonary capillaries, a fundamental mechanism responsible for EIPH, as highlighted in the 2024 Equine Health and Nutrition Conference Proceedings. This approach has proven effective in managing EIPH's risk, aligning with findings that stress on pulmonary capillaries significantly contributes to the condition (Bayly & Van Erck, 2024).

The Path Forward in EIPH Management

Continued research and discussion within the equine community reflect a committed effort to refine and improve strategies for managing EIPH. Insights from the 2024 Equine Health and Nutrition Conference highlight the condition's complexity and underscore the need for a comprehensive management approach that includes advanced tools like FLAIR Strips (Bayly & Van Erck, 2024).

In Summary

The fight against EIPH in competitive equine sports continues, with FLAIR Strips at the forefront of this effort. As we embrace advancements in equine performance, the importance of health and wellness innovations becomes increasingly apparent. Supported by evidence-based solutions, we can achieve new milestones in equine athleticism while ensuring the health and well-being of these remarkable animals.

To read the Kentucky Equine Research Conference 2024 Proceedings, click here:


Bayly, W., & Van Erck, E. (2024). Exercise-Induced Pulmonary Hemorrhage (EIPH): Not Just a Racehorse Disorder. Proceedings of the 2024 Equine Health and Nutrition Conference.